Stereotaxis says the acquisition strengthens its position as “a leading platform for the full spectrum of endovascular procedures.”
Robocath, MicroPort MedBot joint venture to develop, distribute vascular robots in China
China-based MicroPort MedBot and France-based Robocath have formed a joint venture to commercialize the R-One robot-assisted platform for cardiovascular surgery in China.
Robotics investments recap: April 2020
In April 2020, the reality of the COVID-19 shutdowns rippled across industries, slowing investment across the board. However, some sectors, such as logistics and healthcare, continued to receive funding.
Robocath adds $2m for new neurovascular platform
Medical robotics startup Robocath said today that it added about $2 million (€1.7 million) to the more than $5 million it raised earlier this year, taking its total to $7.5 million in funding this year. Rouen, France-based Robocath, which is developing the R-One robotic platform for coronary angioplasty, is pursuing CE Mark approval in the European Union for…
Robocath raises $5.2m for R-one robotic platform
Medical robotics start-up Robocath said today it has raised $5.2 million (EU €4.7 million) in a new round of funding. The round was led by M Capital and Normandie Participations and joined by previous investors Go Capital and NCI, the Rouen, France-based company said. Robocath is developing the R-one robotic platform designed for interventional cardiology,…